SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sanofi India - Quaterly Results

23 Feb 2023 Evaluate
Revenue showed a marginal decline at Rs. 6719.00 millions. For the quarter ended December 2022, as compared to corresponding quarter of last year.Net Profit recorded in the quarter ended December 2022 rise to 44.80% to Rs. 1309.00  millions  compared to R. 904.00 millions in corresponding previous quarter.Operating Profit saw a handsome growth to 1869.00 millions from 1435.00 millions in the quarter ended December 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202212 202112 % Var
Sales 6719.00 6879.00 -2.33 27701.00 29566.00 -6.31 27701.00 29566.00 -6.31
Other Income 200.00 163.00 22.70 715.00 744.00 -3.90 715.00 744.00 -3.90
PBIDT 1869.00 1435.00 30.24 7759.00 8369.00 -7.29 7759.00 8369.00 -7.29
Interest 4.00 4.00 0.00 17.00 18.00 -5.56 17.00 18.00 -5.56
PBDT 2004.00 1431.00 40.04 9062.00 13243.00 -31.57 9062.00 13243.00 -31.57
Depreciation 100.00 109.00 -8.26 419.00 667.00 -37.18 419.00 667.00 -37.18
PBT 1904.00 1322.00 44.02 8643.00 12576.00 -31.27 8643.00 12576.00 -31.27
TAX 595.00 418.00 42.34 2437.00 3132.00 -22.19 2437.00 3132.00 -22.19
Deferred Tax -35.00 -12.00 191.67 -15.00 -228.00 -93.42 -15.00 -228.00 -93.42
PAT 1309.00 904.00 44.80 6206.00 9444.00 -34.29 6206.00 9444.00 -34.29
Equity 230.00 230.00 0.00 230.00 230.00 0.00 230.00 230.00 0.00
PBIDTM(%) 27.82 20.86 33.35 28.01 28.31 -1.05 28.01 28.31 -1.05

Sanofi India Share Price

3493.20 23.65 (0.68%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×